Directly reprogrammed natural killer cells for cancer immunotherapy
- 2 August 2021
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 5 (11) , 1360-1376
Abstract
Efficacious and accessible sources of natural killer (NK) cells would widen their use as immunotherapeutics, particularly for solid cancers. Here, we show that human somatic cells can be directly reprogrammed into NK cells with a CD56brightCD16bright phenotype using pluripotency transcription factors and an optimized reprogramming medium. The directly reprogrammed NK cells have strong innate–adaptive immunomodulatory activity and are highly potent against a wide range of cancer cells, including difficult-to-treat solid cancers and cancer stem cells. Both directly reprogrammed NK cells bearing a cancer-specific chimeric antigen receptor and reprogrammed NK cells in combination with antibodies competent for antibody-dependent cell-mediated cytotoxicity led to selective anticancer effects with augmented potency. The direct reprogramming of human somatic cells into NK cells is amenable to the production of autologous and allogeneic NK cells, and will facilitate the design and testing of cancer immunotherapies and combination therapies.Keywords
Funding Information
- National Research Foundation of Korea (2019M3A9H1103797, 2020R1A2B5B02002252, 2019M3A9H1103797, 2019M3A9H1103797, 2019M3A9H1103797, 2019M3A9H1103797, 2019M3A9H1103797, 2020R1A2B5B02002252)
- National Research Council of Science and Technology (No. CRC-15-02-KRIBB)
This publication has 51 references indexed in Scilit:
- Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I MoleculesThe Journal of Immunology, 2013
- Direct reprogramming of mouse fibroblasts to neural progenitorsProceedings of the National Academy of Sciences, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Direct conversion of human fibroblasts to multilineage blood progenitorsNature, 2010
- Activating and inhibitory receptors of natural killer cellsImmunology & Cell Biology, 2010
- The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cellsBritish Journal of Haematology, 2009
- Human natural killer cellsBlood, 2008
- Cetuximab for the Treatment of Colorectal CancerNew England Journal of Medicine, 2007
- Natural killer cells infiltrating colorectal cancer and MHC class I expressionMolecular Immunology, 2005
- Stepwise Reprogramming of B Cells into MacrophagesCell, 2004